Severity of coronary artery disease in postmenopausal diabetic women

Hormones

Volumn 7, Issue 2, 2008, Pages 148-155

  Saltiki, Katerina ^a   Cimponeriu, Adrianna ^a   Lili, Kyriaki ^a   Peppa, Melpomeni ^b   Anastasiou, Eleni ^a   Alevizaki, Maria ^a  

^a ALEXANDRA HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Atherosclerosis; Cardiovascular disease; Coronary artery disease; Diabetes; Menopause; SHBG

Indexed keywords

SEX HORMONE BINDING GLOBULIN;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; DIABETIC ANGIOPATHY; HOSPITALIZATION; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RADIOGRAPHY;

AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 47949129286     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401506     Document Type: Article

References (48)

1. Isles CG, Hole DJ, Hawthorne VM, Lever AF, 1992 Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet 339: 702-706.
2. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH, 1987 Menopause and the risk of coronary heart disease in women. N Engl J Med 316: 1105-1110. (Pubitemid 17052498)
3. Saltiki K, Doukas C, Kanakakis J, Anastasiou E, Mantzou E, Alevizaki M, 2006 Severity of cardiovascular disease in women: relation with exposure to endogenous estrogen. Maturitas 55: 51-57. (Pubitemid 44109948)
4. Saltiki K, Alevizaki M, 2007 Coronary heart disease in postmenopausal women; the role of endogenous estrogens and their receptors. Hormones (Athens) 6: 9-24.
5. Gurevitz O, Jonas M, Boyko V, Rabinowitz B, Reicher-Reiss H, 2000 Clinical profile and long-term prognosis of women < or = 50 years of age referred for coronary angiography for evaluation of chest pain. Am J Cardiol 85: 806-809. (Pubitemid 30157843)
6. Sowers JR, 1998 Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 158: 617-621. (Pubitemid 28144819)
7. Kaseta JR, Skafar DF, Ram JL, Jacober SJ, Sowers JR, 1999 Cardiovascular disease in the diabetic woman. J Clin Endocrinol Metab 84: 1835-1838.
8. Steinberg HO, Paradisi G, Cronin J, et al, 2000 Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 101: 2040-2046. (Pubitemid 30233166)
9. Alderman EL, Corley SD, Fisher LD, et al, 1993 Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. J Am Coll Cardiol 22: 1141-1154.
10. Pan WH, Cedres LB, Liu K, et al, 1986 Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123: 504-516. (Pubitemid 16101155)
11. Kanaya AM, Grady D, Barrett-Connor E, 2002 Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 162: 1737-1745. (Pubitemid 34894803)
12. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH, 1997 A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 20: 935-942.
13. Miettinen H, Lehto S, Salomaa V, et al, 1998 Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21: 69-75. (Pubitemid 28030388)
14. Kannel WB, McGee DL, 1979 Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038.
15. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M, 1998 Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234. (Pubitemid 28350165)
16. Eckel RH, Kahn R, Robertson RM, Rizza RA, 2006 Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Diabetes Care 29: 1697-1699. (Pubitemid 44127607)
17. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL, 1991 Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265: 627-631.
18. Genuth S, Alberti KG, Bennett P, et al, 2003 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167. (Pubitemid 36928953)
19. Chobanian AV, Bakris GL, Black HR, et al, 2003 Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252. (Pubitemid 37553153)
20. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), 2001 JAMA 285: 2486-2497.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
22. Henry P, Makowski S, Richard P, et al, 1997 Increased incidence of moderate stenosis among patients with diabetes: substrate for myocardial infarction? Am Heart J 134: 1037-1043.
23. Freedman DS, Gruchow HW, Bamrah VS, Anderson AJ, Barboriak JJ, 1988 Diabetes mellitus and arteriographically-documented coronary artery disease. J Clin Epidemiol 41: 659-668. (Pubitemid 18161015)
24. Lemp GF, Vander Zwaag R, et al, 1987 Association between the severity of diabetes mellitus and coronary arterial atherosclerosis. Am J Cardiol 60: 1015-1019. (Pubitemid 17164586)
25. Fallow GD, Singh J, 2004 The prevalence, type and severity of cardiovascular disease in diabetic and non-diabetic patients: a matched-paired retrospective analysis using coronary angiography as the diagnostic tool. Mol Cell Biochem 261: 263-269. (Pubitemid 39004539)
26. Ledru F, Ducimetiere P, Battaglia S, et al, 2001 New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol 37: 1543-1550.
27. Vanhaecke J, Piessens J, Van de Werf F, Willems JL, De Geest H, 1983 Angiographic evolution of coronary atherosclerosis in non-operated patients. Eur Heart J 4: 547-556.
28. Raichlen JS, Healy B, Achuff SC, Pearson TA, 1986 Importance of risk factors in the angiographic progression of coronary artery disease. Am J Cardiol 57: 66-70. (Pubitemid 16136635)
29. Manson JE, Colditz GA, Stampfer MJ, et al, 1991 A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 151: 1141-1147.
30. Mellen PB, Cefalu WT, Herrington DM, 2006 Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women. Arterioscler Thromb Vasc Biol 26: 189-193.
31. Sharaf BL, Pepine CJ, Kerensky RA, et al, 2001 Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol 87: 937-941.
32. Natali A, Vichi S, Landi P, Severi S, L'Abbate A, Ferrannini E, 2000 Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia 43: 632-641. (Pubitemid 30322081)
33. Melidonis A, Dimopoulos V, Lempidakis E, et al, 1999 Angiographic study of coronary artery disease in diabetic patients in comparison with nondiabetic patients. Angiology 50: 997-1006.
34. Pajunen P, Nieminen MS, Taskinen MR, Syvanne M, 1997 Quantitative comparison of angiographic characteristics of coronary artery disease in patients with noninsulin-dependent diabetes mellitus compared with matched nondiabetic control subjects. Am J Cardiol 80: 550-556. (Pubitemid 27386137)
35. Horimoto M, Hasegawa A, Ozaki T, Takenaka T, Igarashi K, Inoue H, 2005 Independent predictors of the severity of angiographic coronary atherosclerosis: the lack of association between impaired glucose tolerance and stenosis severity. Atherosclerosis 182: 113-119. (Pubitemid 41188376)
36. Carr MC, 2003 The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88: 2404-2411.
37. Toth MJ, Sites CK, Eltabbakh GH, Poehlman ET, 2000 Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care 23: 801-806.
38. Peppa M, Uribarri J, Vlassara H, 2002 Advanced glycoxidation. A new risk factor for cardiovascular disease? Cardiovasc Toxicol 2: 275-287.
39. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI, 2003 Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab 88: 1646-1652. (Pubitemid 36623382)
40. Reinecke H, Bogdanski J, Woltering A, et al, 2002 Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am J Cardiol 90: 364-368. (Pubitemid 34895054)
41. Lapidus L, Lindstedt G, Lundberg PA, Bengtsson C, Gredmark T, 1986 Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clin Chem 32: 146-152. (Pubitemid 17033796)
42. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C, Bjorntorp P, 1991 Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 40: 123-128.
43. Sutton-Tyrrell K, Wildman RP, Matthews KA, et al, 2005 Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 111: 1242-1249. (Pubitemid 40389087)
44. Heald AH, Anderson SG, Ivison F, et al, 2005 Low sex hormone binding globulin is a potential marker for the metabolic syndrome in different ethnic groups. Exp Clin Endocrinol Diabetes 113: 522-528. (Pubitemid 41585989)
45. Nestler JE, 1993 Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab 76: 273-274.
46. Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A, 2004 Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 160: 540-548. (Pubitemid 39215630)
47. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE, 2005 Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90: 1929-1935. (Pubitemid 40586223)
48. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O, 2003 Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383-393. (Pubitemid 36159355)